βNew drugs: Kids come firstβ: Children s
βNew drugs: Kids come firstβ: Children should be included in trials of new biological treatments
β
Salvatore Cucchiara; Alessio Morley-Fletcher
π
Article
π
2007
π
John Wiley and Sons
π
English
β 73 KB
The advent of biological therapies has dramatically revolutionized the treatment options for refractory inflammatory bowel disease (IBD). Of all the biologics evaluated to date, infliximab, an anti-tumor necrosis factor-β£ monoclonal chimeric antibody, has been shown to be an extremely potent drug fo